BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 10192659)

  • 21. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
    Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
    Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors.
    Antoniadi T; Hatzis T; Kroupis C; Economou-Petersen E; Petersen MB
    Am J Hematol; 1999 Aug; 61(4):265-7. PubMed ID: 10440914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
    Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
    Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients.
    Eid SS; Shubeilat T
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):417-21. PubMed ID: 16093732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.
    Andrade FL; Annichino-Bizzacchi JM; Saad ST; Costa FF; Arruda VR
    Am J Hematol; 1998 Sep; 59(1):46-50. PubMed ID: 9723576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.
    Zheng YZ; Tong J; Do XP; Pu XQ; Zhou BT
    Br J Haematol; 2000 Jun; 109(4):870-4. PubMed ID: 10929044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
    Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
    Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
    Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.
    Salomon O; Rosenberg N; Zivelin A; Steinberg DM; Kornbrot N; Dardik R; Inbal A; Seligsohn U
    Hematol J; 2001; 2(1):38-41. PubMed ID: 11920232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
    Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
    Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of three genetic traits to venous thrombosis in an African-American population.
    Dilley A; Austin H; Hooper WC; Lally C; Ribeiro MJ; Wenger NK; Silva V; Rawlins P; Evatt B
    Am J Epidemiol; 1998 Jan; 147(1):30-5. PubMed ID: 9440395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.
    Guédon C; Le Cam-Duchez V; Lalaude O; Ménard JF; Lerebours E; Borg JY
    Am J Gastroenterol; 2001 May; 96(5):1448-54. PubMed ID: 11374681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.